Literature DB >> 28323952

Randomized Controlled Trial of a MUFA or Fiber-Rich Diet on Hepatic Fat in Prediabetes.

Isabel Errazuriz1, Simmi Dube1, Michael Slama1, Roberto Visentin2, Sunita Nayar3, Helen O'Connor3, Claudio Cobelli2, Swapan Kumar Das4, Ananda Basu1, Walter Karl Kremers5, John Port6, Rita Basu1.   

Abstract

Context: Increased prevalence of type 2 diabetes mellitus and prediabetes worldwide is attributed in part to an unhealthy diet. Objective: To evaluate whether 12 weeks of high monounsaturated fatty acid (MUFA) or fiber-rich weight-maintenance diet lowers hepatic fat and improves glucose tolerance in people with prediabetes. Design: Subjects underwent a [6, 6-2H2]-labeled 75-g oral glucose tolerance test to estimate hepatic insulin sensitivity and liver fat fraction (LFF) using magnetic resonance spectroscopy before and after intervention. Setting: Mayo Clinic Clinical Research Trials Unit. Participants: 43 subjects with prediabetes. Intervention: Subjects were randomized into three isocaloric weight-maintaining diets containing MUFA (olive oil), extra fiber, and standard US food (control-habitual diet). Outcome Measures: LFF, glucose tolerance, and indices of insulin action and secretion.
Results: Body weight was maintained constant in all groups during the intervention. Glucose and hormonal concentrations were similar in all groups before, and unchanged after, 12 weeks of intervention. LFF was significantly lower after intervention in the MUFA group (P < 0.0003) but remained unchanged in the fiber (P = 0.25) and control groups (P = 0.45). After 12 weeks, LFF was significantly lower in the MUFA than in the control group (P = 0.01), but fiber and control groups did not differ (P = 0.41). Indices of insulin action and secretion were not significantly different between the MUFA and control groups after intervention (P ≥ 0.11), but within-group comparison showed higher hepatic (P = 0.01) and total insulin sensitivity (P < 0.04) with MUFA. Conclusions: Twelve weeks of a MUFA diet decreases hepatic fat and improves both hepatic and total insulin sensitivity.
Copyright © 2017 Endocrine Society

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28323952      PMCID: PMC5443322          DOI: 10.1210/jc.2016-3722

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  34 in total

1.  A position statement on NAFLD/NASH based on the EASL 2009 special conference.

Authors:  Vlad Ratziu; Stefano Bellentani; Helena Cortez-Pinto; Chris Day; Giulio Marchesini
Journal:  J Hepatol       Date:  2010-05-07       Impact factor: 25.083

Review 2.  Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review.

Authors:  Christian Thoma; Christopher P Day; Michael I Trenell
Journal:  J Hepatol       Date:  2011-07-01       Impact factor: 25.083

3.  Hepatic insulin sensitivity in healthy and prediabetic subjects: from a dual- to a single-tracer oral minimal model.

Authors:  Roberto Visentin; Chiara Dalla Man; Rita Basu; Ananda Basu; Robert A Rizza; Claudio Cobelli
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-05-19       Impact factor: 4.310

4.  Three weeks on a high-fat diet increases intrahepatic lipid accumulation and decreases metabolic flexibility in healthy overweight men.

Authors:  Noud A van Herpen; Vera B Schrauwen-Hinderling; Gert Schaart; Ronald P Mensink; Patrick Schrauwen
Journal:  J Clin Endocrinol Metab       Date:  2011-01-20       Impact factor: 5.958

5.  Serum alanine aminotransferase levels decrease further with carbohydrate than fat restriction in insulin-resistant adults.

Authors:  Marno Celeste Ryan; Fahim Abbasi; Cindy Lamendola; Susan Carter; Tracey Lynn McLaughlin
Journal:  Diabetes Care       Date:  2007-03-10       Impact factor: 19.112

6.  Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial.

Authors:  Helena Bjermo; David Iggman; Joel Kullberg; Ingrid Dahlman; Lars Johansson; Lena Persson; Johan Berglund; Kari Pulkki; Samar Basu; Matti Uusitupa; Mats Rudling; Peter Arner; Tommy Cederholm; Håkan Ahlström; Ulf Risérus
Journal:  Am J Clin Nutr       Date:  2012-04-04       Impact factor: 7.045

7.  Dietary fat content modifies liver fat in overweight nondiabetic subjects.

Authors:  Jukka Westerbacka; Katriina Lammi; Anna-Maija Häkkinen; Aila Rissanen; Irma Salminen; Antti Aro; Hannele Yki-Järvinen
Journal:  J Clin Endocrinol Metab       Date:  2005-03-01       Impact factor: 5.958

8.  Liver fat is reduced by an isoenergetic MUFA diet in a controlled randomized study in type 2 diabetic patients.

Authors:  Lutgarda Bozzetto; Anna Prinster; Giovanni Annuzzi; Lucia Costagliola; Anna Mangione; Alessandra Vitelli; Raffaella Mazzarella; Margaret Longobardo; Marcello Mancini; Carlo Vigorito; Gabriele Riccardi; Angela A Rivellese
Journal:  Diabetes Care       Date:  2012-07       Impact factor: 19.112

9.  Reducing Liver Fat by Low Carbohydrate Caloric Restriction Targets Hepatic Glucose Production in Non-Diabetic Obese Adults with Non-Alcoholic Fatty Liver Disease.

Authors:  Haoyong Yu; Weiping Jia; ZengKui Guo
Journal:  J Clin Med       Date:  2014-09       Impact factor: 4.241

10.  Genetic predisposition in NAFLD and NASH: impact on severity of liver disease and response to treatment.

Authors:  Paola Dongiovanni; Quentin M Anstee; Luca Valenti
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

View more
  20 in total

Review 1.  Effects of dietary macronutrients on liver fat content in adults: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Esther Winters-van Eekelen; Inge Verkouter; Harry P F Peters; Marjan Alssema; Babette G de Roos; Vera B Schrauwen-Hinderling; Kay H M Roumans; Jan W Schoones; Peter L Zock; Patrick Schrauwen; Frits R Rosendaal; Olaf M Dekkers; Renée de Mutsert
Journal:  Eur J Clin Nutr       Date:  2020-10-22       Impact factor: 4.016

Review 2.  Efficacy of Dietary Manipulations for Depleting Intrahepatic Triglyceride Content: Implications for the Management of Non-alcoholic Fatty Liver Disease.

Authors:  Karoline Sandby; Nina Rica Wium Geiker; Maria Dalamaga; Henning Grønbæk; Faidon Magkos
Journal:  Curr Obes Rep       Date:  2021-02-13

Review 3.  Mediterranean Diet and Multi-Ingredient-Based Interventions for the Management of Non-Alcoholic Fatty Liver Disease.

Authors:  Manuel Suárez; Noemí Boqué; Josep M Del Bas; Jordi Mayneris-Perxachs; Lluís Arola; Antoni Caimari
Journal:  Nutrients       Date:  2017-09-22       Impact factor: 5.717

4.  Effects of a multifactorial ecosustainable isocaloric diet on liver fat in patients with type 2 diabetes: randomized clinical trial.

Authors:  Giuseppe Della Pepa; Claudia Vetrani; Valentina Brancato; Marilena Vitale; Serena Monti; Giovanni Annuzzi; Gianluca Lombardi; Anna Izzo; Marianna Tommasone; Paola Cipriano; Gennaro Clemente; Peppino Mirabelli; Marcello Mancini; Marco Salvatore; Gabriele Riccardi; Angela Albarosa Rivellese; Lutgarda Bozzetto
Journal:  BMJ Open Diabetes Res Care       Date:  2020-05

Review 5.  Ectopic Fat Accumulation in Distinct Insulin Resistant Phenotypes; Targets for Personalized Nutritional Interventions.

Authors:  Inez Trouwborst; Suzanne M Bowser; Gijs H Goossens; Ellen E Blaak
Journal:  Front Nutr       Date:  2018-09-04

6.  Overeating Saturated Fat Promotes Fatty Liver and Ceramides Compared With Polyunsaturated Fat: A Randomized Trial.

Authors:  Fredrik Rosqvist; Joel Kullberg; Marcus Ståhlman; Jonathan Cedernaes; Kerstin Heurling; Hans-Erik Johansson; David Iggman; Helena Wilking; Anders Larsson; Olof Eriksson; Lars Johansson; Sara Straniero; Mats Rudling; Gunnar Antoni; Mark Lubberink; Marju Orho-Melander; Jan Borén; Håkan Ahlström; Ulf Risérus
Journal:  J Clin Endocrinol Metab       Date:  2019-12-01       Impact factor: 5.958

7.  Decreased Consumption of Added Fructose Reduces Waist Circumference and Blood Glucose Concentration in Patients with Overweight and Obesity. The DISFRUTE Study: A Randomised Trial in Primary Care.

Authors:  Santiago Domínguez-Coello; Lourdes Carrillo-Fernández; Jesús Gobierno-Hernández; Manuel Méndez-Abad; Carlos Borges-Álamo; José Antonio García-Dopico; Armando Aguirre-Jaime; Antonio Cabrera-de León
Journal:  Nutrients       Date:  2020-04-19       Impact factor: 5.717

Review 8.  Nutrients, Genetic Factors, and Their Interaction in Non-Alcoholic Fatty Liver Disease and Cardiovascular Disease.

Authors:  Rosa Lombardi; Federica Iuculano; Giada Pallini; Silvia Fargion; Anna Ludovica Fracanzani
Journal:  Int J Mol Sci       Date:  2020-11-19       Impact factor: 5.923

Review 9.  Dietary carbohydrates and fats in nonalcoholic fatty liver disease.

Authors:  Hannele Yki-Järvinen; Panu K Luukkonen; Leanne Hodson; J Bernadette Moore
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-07-13       Impact factor: 46.802

10.  Dietary fibre and whole grains in diabetes management: Systematic review and meta-analyses.

Authors:  Andrew N Reynolds; Ashley P Akerman; Jim Mann
Journal:  PLoS Med       Date:  2020-03-06       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.